USPTO trademark

NUMYZA

Under examinationUSPTOWord markClass 5

"NUMYZA" is a word mark owned by Foxland Pharmaceuticals, Inc., filed at the USPTO on August 17, 2026. It is under examination and covers class 5 (Pharmaceuticals).

Get this data via the API
Official USPTO record
NUMYZA trademark as filed
As filed with the USPTO
Status
Under examination
Since August 17, 2026
Filed
August 17, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50055497
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns NUMYZA

The owner and representative on file with the office.

Owner

Foxland Pharmaceuticals, Inc.

Hazlet, United States

Representative

Samar Aryani-Sabet

Blank Rome LLP

Goods and services

What the mark covers

The products and services NUMYZA is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, and moderate to severe pain in adults

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. New application office supplied data entered
  3. New application entered
FAQ

About NUMYZA

Who owns the trademark "NUMYZA"?

The USPTO trademark "NUMYZA" (application 50055497) is owned by Foxland Pharmaceuticals, Inc.

What is the status of "NUMYZA"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull NUMYZA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a01503-6979-757d-aeaf-3e10821f215e
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a01503-6979-757d-aeaf-3e10821f215e",
  "object": "trademark",
  "mark_text": "NUMYZA",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50055497",
  "filing_date": "2026-08-17",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Foxland Pharmaceuticals, Inc.",
      "entity_id": null
    }
  ]
}